Gilead Sciences' new drug Sovaldi effectively cures hepatitis C, but the price is straining state budgets. Eric Risberg/AP hide caption
sovaldi sovaldi
Gilead Sciences' new drug Sovaldi effectively cures hepatitis C, but the price is straining state budgets. Eric Risberg/AP hide caption
Sovaldi, a daily oral treatment for hepatitis C, costs $1,000 a pill. Courtesy of Gilead Sciences hide caption